These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16247733)

  • 1. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities.
    Alete DE; Racher AJ; Birch JR; Stansfield SH; James DC; Smales CM
    Proteomics; 2005 Dec; 5(18):4689-704. PubMed ID: 16247733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
    Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
    Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
    Smales CM; Dinnis DM; Stansfield SH; Alete D; Sage EA; Birch JR; Racher AJ; Marshall CT; James DC
    Biotechnol Bioeng; 2004 Nov; 88(4):474-88. PubMed ID: 15459912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular portrait of high productivity in recombinant NS0 cells.
    Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS
    Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
    Krampe B; Swiderek H; Al-Rubeai M
    Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2004 Jan; 85(2):115-21. PubMed ID: 14704993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale gene expression analysis of cholesterol dependence in NS0 cells.
    Seth G; Philp RJ; Denoya CD; McGrath K; Stutzman-Engwall KJ; Yap M; Hu WS
    Biotechnol Bioeng; 2005 Jun; 90(5):552-67. PubMed ID: 15830340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
    Wu MH; Dimopoulos G; Mantalaris A; Varley J
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.
    Barnes LM; Bentley CM; Moy N; Dickson AJ
    Biotechnol Bioeng; 2007 Feb; 96(2):337-48. PubMed ID: 17001634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
    Khoo SH; Falciani F; Al-Rubeai M
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
    Veraitch FS; Al-Rubeai M
    Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.
    Ho Y; Varley J; Mantalaris A
    Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genome-wide analysis of antibody producing NS0 cell line cultivated at different temperatures.
    Swiderek H; Al-Rubeai M
    Biotechnol Bioeng; 2007 Oct; 98(3):616-30. PubMed ID: 17421047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell line-specific control of recombinant monoclonal antibody production by CHO cells.
    O'Callaghan PM; McLeod J; Pybus LP; Lovelady CS; Wilkinson SJ; Racher AJ; Porter A; James DC
    Biotechnol Bioeng; 2010 Aug; 106(6):938-51. PubMed ID: 20589672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
    Dinnis DM; James DC
    Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global assessment of protein turnover in recombinant antibody producing myeloma cells.
    Yee JC; Jacob NM; Jayapal KP; Kok YJ; Philp R; Griffin TJ; Hu WS
    J Biotechnol; 2010 Aug; 148(4):182-93. PubMed ID: 20540971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic profiling of CHO cells with enhanced rhBMP-2 productivity following co-expression of PACEsol.
    Meleady P; Henry M; Gammell P; Doolan P; Sinacore M; Melville M; Francullo L; Leonard M; Charlebois T; Clynes M
    Proteomics; 2008 Jul; 8(13):2611-24. PubMed ID: 18546152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.